Arnold Ventures’ 2024 Grant Awards Are Now Public. Here’s What Those Dollars Say About the Group’s Goals

It’s a big day for PDABs. Buckle up.  *** The biggest news is probably Amgen’s suit against the state of Colorado that makes the case that the prescription drug affordability

Scheduling Note: Cost Curve is off tomorrow, back on Monday. Oh, we’re heavy into transparency report season now. I’ve dug up two additional sources for list- and net-price changes, which

There’s not a whole lot to say about the 340B alternative dispute resolution rules (at least, not a whole lot that I can say). It seems like providers are basically